The public-interest art exhibition in a Beijing bookstore is dedicated to raising awareness on tenosynovial giant cell tumor, a rare joint disorder. LI HENG/XINHUA In the courtyard of Beijing's ...

The drug targets the overgrowth of synovial cells and inflammatory components that drive tumor development and joint ...

Vimseltinib is the first and only therapy with a positive CHMP opinion for the treatment of TGCT in the European Union Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discoverin ...

Deciphera Pharmaceuticals, LLC, a biopharmaceutical company focused on discovering, developing, and commercializing important ...

Four months after giving Eli Lilly’s Alzheimer’s disease treatment a thumbs-down, Europe’s Committee for Medicinal Products ...

ASCO 2025 showcased breakthroughs in sarcoma treatment, emphasizing precision medicine, immunotherapy, and promising new ...

The researchers used genetically engineered mouse models, human colon cancer cell lines, and organoid cultures to analyze how deletion or overexpression of CDX1/2 affected tumor behavior.

A hydrogel-based barrier boosts cancer immunotherapy by shielding T cells from exhaustion, leading to stronger and longer-lasting immune responses.

Peer-Reviewed Study Validates Renovaro's Genetically Engineered Dendritic Cell Therapy with Potent Anti-Tumor Efficacy Provided by ACCESS Newswire Jul 17, 2025, 6:15:00 AM ...

Delays in starting tocilizumab therapy for giant cell arteritis are caused partly by delays in insurance approval, and costs vary by insurance type, study finds.